Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve a) To consider and ....
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Syncom Formulations India has informed the stock exchanges that its Board of Directors will meet on Monday, 19 May 2025 at 4:00 PM at its corporate office in Indore. The main agenda is to consider and approve the standalone and consolidated audited financial results for the quarter and financial year ended 31 March 2025. The Board will also take on record the auditor's audit report for these results. The company noted that the trading window closure details have already been updated with the designated depository. This is a routine regulatory filing under SEBI LODR Regulation 29(1)(a) and does not contain any actual financial numbers.
No direct impact on shareholders or stock price from this filing alone — it is a standard advance notice that audited annual and Q4 results will be declared on 19 May 2025. Investors should watch for the actual results announcement for any meaningful insights into the company's FY25 performance.